ATTENDEES' STORIES

Hear Why You Cannot Miss This Event Directly From Your Peers:

Aarvik

Outstanding

Ajinomoto-Bio-Pharma-Services_news_large

An amazing opportunity to meet many ADC companies in person

Angiex Inc. is a privately held biotech startup whose mission is to exploit newly discovered biological transport mechanisms to make drugs with revolutionary power over cancer. Based in Cambridge, Mass., Angiex was founded by a scientific team of leading experts in angiogenesis, vascular biology, and oncology.

Great event, with great talks, educational, and great networking opportunities, especially for those that are new to the ADC world

Antikor

The best just got bigger and even better!

astrazeneca

The one-stop shop for all the latest updates in the ADC field

bristol-myers-squibb-new-logo (1)

The content is great, covering the most recent discovery in all fields of ADC. Very informative and helpful

BSP Pharmaceuticals

The summit continues to be the main reference event for ADCs, supported by all the most relevant players in the space

Daiichi

Excellent opportunity to hear about recent advances in all areas of ADC development. The quality of the presenters and the information was excellent. I enjoyed meeting with former colleagues and new people

Eli_Lilly_and_Company.svg

Packed agenda with good topics and speakers

Heidelberg Updated

The best ADC conference, with great speakers and attendees

Janssen

High-quality talks, and networking possibilities

Mersana

I enjoyed the variety of presentations and tracks, as well as the plenary and networking opportunities

logo-merck

This meeting will provide a great opportunity for our peers to learn the new techniques used for ADC development...We may find new ideas and new solutions for our own programs or projects

ABBVIE

To understand better the landscape, the evolution of development, and to have great opportunities to exchange the learnings and understandings with industrial peers in the field of ADC

novartis-vector-logo

ADCs are entering a new era that harnesses payloads with specific mechanisms of action beyond pan-cytotoxicity. This makes ADCs even more complex, further emphasizing the need for early establishment of a clear mechanistic link between ADC design, pharmacokinetics, and desired pharmacodynamics

ELU

I can't miss the meeting. I just can't

astrazeneca

There is something to be learned from every presentation, and it also represents a fantastic opportunity to chat in person with representatives from all corners of the ADC world

BIO

This conference is the one opportunity timely updating ADC therapeutics with the world experts to have comprehensive discussion

Sanofi_640 (1)

A broad view from preclinic to clinic and CMC of the ADC field. Very rich experience showcasing big trends for the ADC field

Sutro_Biopharma_Inc_logo

The diversity of the attendees was really fantastic

Zentalis

Enjoyed seeing people from around the world working in this field and learned about the state of the art of research and development

ADC SD Social Card (1)